Clinical Trials Logo

Clinical Trial Summary

Reduction of the indication for radiotherapy (RT) in newly diagnosed patients with classical Hodgkins lymphoma without compromising cure rates. Investigation of a chemotherapy intensification randomisation in intermediate and advanced classical Hodgkins lymphoma patients to compensate for reduction in RT.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02797717
Study type Interventional
Source Rabin Medical Center
Contact Galia Avrahami, MD
Phone 972-3-9253356
Email Galia2@clalit.org.il
Status Recruiting
Phase N/A
Start date November 2015
Completion date December 2027